HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

4th Edition of

International Public Health Conference

March 24-26, 2025 | Singapore

IPHC 2022

Taha Mollah

Speaker at Public Health Conference 2022 - Taha Mollah
St Vincent's Hospital Melbourne, Australia
Title : A population based comparative analysis of gallbladder associated admission and cholecystectomy rates across Australia and Aotearoa New Zealand 2000 2019

Abstract:

Aims: we aimed to provide a contemporary update on the trends of symptomatic gallbladder-associated hospital admissions and cholecystectomy in Australia and Aotearoa New Zealand (NZ). 

Methods: national healthcare registries were used to obtain data on all episodes of cholecystectomy and hospital admissions for patients ≥15 years from public and private healthcare institutions.

Results: In Australia 2000-2019 there were 1,331,631 hospital admissions and 964,097 cholecystectomies, 873,249 90.6% laparoscopic. In NZ 2004-2019 there were 163,084 admissions and 98,294 cholecystectomies. The 15 - 54 year old age group saw operative / admission rates increase by +4.0% / +1.9% in Australia and +6.6% / +4.9% in NZ. Hospital admissions decreased -11.3% in Australia but rose +7.3% in NZ. Cholecystectomy rates declined by -4.1% in Australia and rose +6.8% in NZ. Intervention rate has risen in Australia by 11.8% 67.1% to 75.0% of hospital admissions

Conclusion: there has been a decline in symptomatic gallbladder-associated hospital admissions and interventions in Australia, but a rise in NZ with a shift to the 15 - 54 year age group. Future research should focus on identifying risk factors for increased disease and operative interventions amongst younger demographics. 

Biography:

Dr. Taha Mollah is a general surgical trainee at St. Vincent’s Hospital in Melbourne with a special interest in public health. He graduated with first class honours from Monash University, Australia in 2018 and has previously presented on the epidemiology of gallbladder cancer and inflammatory bowel disease.

Watsapp